Chinese Journal of Cancer Research

Top Research Topics at Chinese Journal of Cancer Research?

The primary areas of discussion in the journal are Internal medicine, Pathology, Cancer, Molecular biology and Oncology. It discusses concepts in Chemotherapy, Breast cancer and Stage (cooking) under Internal medicine and how they intertwine with disciplines like Medicine public health. It connects the study in Chemotherapy with the closely related area of Radiation therapy.

While Pathology is the focus of Chinese Journal of Cancer Research, it also provided insights into the studies of Cancer research, Metastasis and Adenocarcinoma. The studies on Cancer research discussed can also contribute to research in the domains of Carcinogenesis, Immunology and Cell growth. Chinese Journal of Cancer Research facilitates discussions on Cancer that incorporate concepts from other fields like Surgery and Incidence (epidemiology).

It holds forums on Molecular biology that merges themes from other disciplines such as Cell culture, Gene, Transfection, In vitro and Apoptosis. Apoptosis and Flow cytometry are closely related fields of research discussed in the journal. The work tackled in it goes beyond the discipline of Oncology as it also encompasses Colorectal cancer.

• Internal medicine (29.31%)
• Pathology (21.54%)
• Cancer (18.18%)

What are the most cited papers published in the journal?

• Cancer incidence and mortality in China, 2014. (466 citations)
• Annual report on status of cancer in China, 2011 (394 citations)
• Report of incidence and mortality in China cancer registries, 2009 (235 citations)

Research areas of the most cited articles at Chinese Journal of Cancer Research:

The most cited publications mainly tackle studies in Cancer, Internal medicine, Pathology, Oncology and Cancer research. The studies on Cancer discussed at the published articles can also contribute to research in the domains of Mortality rate, Incidence (epidemiology) and Gerontology. The published articles address concerns in Internal medicine which are intertwined with other disciplines, such as Gastroenterology and Immune system.

What topics the last edition of the journal is best known for?

• Cancer
• Internal medicine
• Gene

The previous edition focused in particular on these issues:

The aim of the journal is to expand the discussion of research in Internal medicine, Cancer, Cancer research, Confidence interval and Colorectal cancer. While work presented in the journal provided substantial information on Internal medicine, it also covered topics in Gastroenterology and Oncology. The journal explores topics in Oncology which can be helpful for research in disciplines like Neoadjuvant therapy, Pathological and Immunotherapy.

Topics in Cancer explored in it were investigated in conjunction with research in Stomach and Surgery, Dissection. While Chinese Journal of Cancer Research focused on Cancer research, it was also able to explore topics like Immunohistochemistry and Immune system. In Chinese Journal of Cancer Research, Population based, Cell and Incidence (epidemiology) are investigated in conjunction with one another to address concerns in Colorectal cancer research.

The most cited articles from the last journal are:

• Colorectal cancer burden and trends: Comparison between China and major burden countries in the world. (4 citations)
• Multicenter phase II study of apatinib single or combination therapy in HER2-negative breast cancer involving chest wall metastasis. (2 citations)
• Laparoscopic vs. open surgery for gastrointestinal stromal tumors of esophagogastric junction: A multicenter, retrospective cohort analysis with propensity score weighting. (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Chinese Journal of Cancer Research (based on the number of publications) are:

• Wanqing Chen (42 papers) published 4 papers at the last edition, 1 less than at the previous edition,
• Jiafu Ji (39 papers) published 1 paper at the last edition, 3 less than at the previous edition,
• Rongshou Zheng (28 papers) published 1 paper at the last edition, 1 less than at the previous edition,
• Siwei Zhang (23 papers) published 1 paper at the last edition the same number as at the previous edition,
• Xuetao Cao (20 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Chinese Journal of Cancer Research (based on the number of publications) are:

• Peking University (333 papers) published 14 papers at the last edition, 12 less than at the previous edition,
• Peking Union Medical College (220 papers) published 15 papers at the last edition, 4 less than at the previous edition,
• China Medical University (PRC) (109 papers) published 1 paper at the last edition,
• Fudan University Shanghai Medical College (78 papers) absent at the last edition,
• Fudan University (62 papers) published 3 papers at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 2.22% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 65.91% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.36% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 18.18% of all publications and 4.55% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Oncology

Utilizing the advanced knowledge gained through research, many medical professionals and scientists can pursue rewarding career opportunities in the field of oncology. For example, registered nurses specializing in oncology play a vital role in cancer care, providing critical training, medication administration, and emotional support to patients and their families. The career path to becoming an oncology nurse involves specialized education and experience in the broader field of nursing.

If you're interested in this field, learning about the necessary steps to become a registered nurse in specific regions could be beneficial. For instance, the process to become a registered nurse in Delaware might differ from other states. Find detailed information and professional advice on how to become a registered nurse in Delaware for a clearer career path.

Furthermore, the immense knowledge gathering from journals like the Chinese Journal of Cancer Research can help aspiring registered nurses and other medical professionals to understand the latest developments, techniques, and challenges in oncology. This information can be crucial for their role in providing effective patient care and evolving with advances in the field.